Malignant Appendix Neoplasm — Trials

Malignant Appendix Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03074513	Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors	active not recruiting	Phase 2	133	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT06399757	A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors	active not recruiting	Phase 1 / Phase 2	100	Apollo Therapeutics LtdINDUSTRY	1	Aug 13, 2026	clinicaltrials